• Reduction of oxidative storage lesion for red cells using Hemanext system in clinical trial in hematology patients.
  • Improved platelet products for hemotherapy of HLA-alloimmunized, platelet-refractory patients: platelets made HLA class I deficient by acid treatment.
  • Freeze-drying of platelets for treatment of difficult diabetic wounds.
  • Examination of new phthalate-free filters and plastics for blood products. Immunomodulating effects of the mushroom extract, AndosanTM, in asthma patients and monitoring with a novel mast cell activation test for allergens. 
  • Anti-COVID-19 effect of AndosanTM in cell cultures.  
Page visits: 541